4.6 Review

Transcription factor ZBP-89 in cancer growth and apoptosis

Journal

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume 1806, Issue 1, Pages 36-41

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbcan.2010.03.002

Keywords

ZBP-89; p53; p21(waf1); Apoptosis; Cancer

Funding

  1. Council of the Hong Kong [CUHK 4551/05M, CUHK 462009]

Ask authors/readers for more resources

ZBP-89, a Kruppel-type zinc-finger transcription factor that binds to GC-rich sequences, is involved in the regulation of cell growth and cell death. It maps to chromosome 3q21 and is composed of 794 residues. Having bifunctional regulatory domains, ZBP-89 may function as a transcriptional activator or repressor of variety of genes such as p16 and vimentin. ZBP-89 arrests cell proliferation through its interactions with p53 and p21(waf1). It is able to stabilize p53 through directly binding and enhance p53 transcriptional activity by retaining it in the nucleus. In addition, ZBP-89 potentiates in butyrate-induced endogenous p21(waf1) up-regulation. ZBP-89 is usually over-expressed in human cancer cells, where it can efficiently induce apoptosis through p53-dependent and -independent mechanisms. Moreover, ZBP-89 is capable of enhancing killing effects of several anti-cancer drugs. Therefore, ZBP-89 may be served as a potential target in cancer therapy. (C) 2010 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available